Scilex Holding Co
For the period ended Sep 30, 2024. Filed Jan 17, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Jan 17, 2025
SCLX$1.74+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except for par value and share amounts)
| September 30,2024 | December 31,2023 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $77 | $3,921 |
| Accounts receivable, net | 31,580 | 34,597 |
| Inventory | 2,404 | 4,214 |
| Prepaid expenses and other | 5,794 | 4,049 |
| Total current assets | 39,855 | 46,781 |
| Property and equipment, net | 711 | 722 |
| Operating lease right-of-use asset | 2,396 | 2,943 |
| Intangibles, net | 33,454 | 36,485 |
| Investments | 2,375 | — |
| Goodwill | 13,481 | 13,481 |
| Other long-term assets | 8,158 | 897 |
| Total assets | $100,430 | $101,309 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $43,400 | $40,954 |
| Accrued payroll | 975 | 2,681 |
| Accrued rebates and fees | 141,709 | 89,658 |
| Accrued expenses | 9,671 | 7,408 |
| Current portion of deferred consideration | 458 | 491 |
| Debt, current | 84,636 | 108,429 |
| Current portion of operating lease liabilities | 688 | 759 |
| Total current liabilities | 281,537 | 250,380 |
| Long-term portion of deferred consideration | 2,556 | 2,895 |
| Debt, net of issuance costs | 14,332 | 17,038 |
| Derivative liabilities | 11,453 | 1,518 |
| Operating lease liabilities | 1,714 | 2,237 |
| Other long-term liabilities | 155 | 179 |
| Total liabilities | 311,747 | 274,247 |
| Commitments and contingencies (See Note 11) | ||
| Stockholders’ deficit: | ||
| Preferred stock, $0.0001 par value, 45,000,000 shares authorized; 29,057,097 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | — | — |
| Common stock, $0.0001 par value, 740,000,000 shares authorized; 191,790,520 shares issued and 131,721,935 shares outstanding as of September 30, 2024; 160,084,250 shares issued and 100,015,665 shares outstanding as of December 31, 2023 | 19 | 16 |
| Additional paid-in capital | 430,767 | 407,813 |
| Accumulated other comprehensive income | 5,011 | — |
| Accumulated deficit | (556,592) | (490,245) |
| Treasury stock, at cost; 60,068,585 shares as of each of September 30, 2024 and December 31, 2023 | (90,522) | (90,522) |
| Total stockholders’ deficit | (211,317) | (172,938) |
| Total liabilities and stockholders’ deficit | $100,430 | $101,309 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.